Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

NCT01077908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

BIOLOGICAL: Adoptive Cellular Therapy
DRUG: Best available antiviral drug therapy

Sponsor

Cell Medica Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]